229 related articles for article (PubMed ID: 33648805)
1. Applications of next-generation sequencing in hematologic malignancies.
Ramkissoon LA; Montgomery ND
Hum Immunol; 2021 Nov; 82(11):859-870. PubMed ID: 33648805
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations crossing the borders of distinct hematopoetic lineages and solid tumors: Diagnostic challenges in the era of high-throughput sequencing in hemato-oncology.
Shumilov E; Flach J; Pabst T; Fiedler M; Angelillo-Scherrer A; Trümper L; Joncourt R; Kohlmann A; Bacher U
Crit Rev Oncol Hematol; 2018 Jun; 126():64-79. PubMed ID: 29759569
[TBL] [Abstract][Full Text] [Related]
3. Principles of analytical validation of next-generation sequencing based mutational analysis for hematologic neoplasms in a CLIA-certified laboratory.
Kanagal-Shamanna R; Singh RR; Routbort MJ; Patel KP; Medeiros LJ; Luthra R
Expert Rev Mol Diagn; 2016; 16(4):461-72. PubMed ID: 26765348
[TBL] [Abstract][Full Text] [Related]
4. Molecular Pathology: Prognostic and Diagnostic Genomic Markers for Myeloid Neoplasms.
Kuo FC
Surg Pathol Clin; 2016 Sep; 9(3):475-88. PubMed ID: 27523973
[TBL] [Abstract][Full Text] [Related]
5. Digital PCR: A Reliable Tool for Analyzing and Monitoring Hematologic Malignancies.
Coccaro N; Tota G; Anelli L; Zagaria A; Specchia G; Albano F
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32365599
[TBL] [Abstract][Full Text] [Related]
6. Improving the detection of patients with inherited predispositions to hematologic malignancies using next-generation sequencing-based leukemia prognostication panels.
DiNardo CD; Routbort MJ; Bannon SA; Benton CB; Takahashi K; Kornblau SM; Luthra R; Kanagal-Shamanna R; Medeiros LJ; Garcia-Manero G; M Kantarjian H; Futreal PA; Meric-Bernstam F; Patel KP
Cancer; 2018 Jul; 124(13):2704-2713. PubMed ID: 29682723
[TBL] [Abstract][Full Text] [Related]
7. Routine clinical mutation profiling using next generation sequencing and a customized gene panel improves diagnostic precision in myeloid neoplasms.
Bartels S; Schipper E; Hasemeier B; Kreipe H; Lehmann U
Oncotarget; 2016 May; 7(21):30084-93. PubMed ID: 27029036
[TBL] [Abstract][Full Text] [Related]
8. Impact of next generation sequencing results on clinical management in patients with hematological disorders.
Patel BJ; Barot SV; Xie Y; Cook JR; Carraway HE; Hsi ED
Leuk Lymphoma; 2021 Jul; 62(7):1702-1710. PubMed ID: 33533694
[TBL] [Abstract][Full Text] [Related]
9. [NGS-based multi-gene panel testing in hematological malignancies: therapeutic significance].
Maeda T
Rinsho Ketsueki; 2022; 63(4):302-307. PubMed ID: 35491220
[TBL] [Abstract][Full Text] [Related]
10. Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs*12) from artifact in myeloid malignancies using NGS.
Alberti MO; Srivatsan SN; Shao J; McNulty SN; Chang GS; Miller CA; Dunlap JB; Yang F; Press RD; Gao Q; Ding L; Heusel JW; Duncavage EJ; Walter MJ
Leukemia; 2018 Aug; 32(8):1874-1878. PubMed ID: 29959414
[No Abstract] [Full Text] [Related]
11. [Recommendations for laboratory standardization of next generation sequencing in hematological malignancies].
Xu CS; Li XQ; Liu HX; Li CB; Chen Z; Cai JP; Peng MT
Zhonghua Yi Xue Za Zhi; 2019 Nov; 99(41):3204-3208. PubMed ID: 31694113
[TBL] [Abstract][Full Text] [Related]
12. Approach Toward Germline Predisposition Syndromes in Patients with Hematologic Malignancies.
Atluri H; Gerstein YS; DiNardo CD
Curr Hematol Malig Rep; 2022 Dec; 17(6):275-285. PubMed ID: 36279069
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after targeted treatment based on somatic tumor genetic testing for women with gynecologic cancers.
Somasegar S; Hoppenot C; Kuchta K; Sereika A; Khandekar J; Rodriguez G; Moore E; Hurteau J; Vogel TJ
Gynecol Oncol; 2021 Nov; 163(2):220-228. PubMed ID: 34511240
[TBL] [Abstract][Full Text] [Related]
14. Targeted next-generation sequencing using a multigene panel in myeloid neoplasms: Implementation in clinical diagnostics.
Maes B; Willemse J; Broekmans A; Smets R; Cruys B; Put N; Madoe V; Janssen M; Soepenberg O; Bries G; Vrelust I; Achten R; Van Pelt K; Buvé K; Theunissen K; Peeters V; Froyen G
Int J Lab Hematol; 2017 Dec; 39(6):604-612. PubMed ID: 28722833
[TBL] [Abstract][Full Text] [Related]
15. Minimal Residual Disease Monitoring with Next-Generation Sequencing Methodologies in Hematological Malignancies.
Sánchez R; Ayala R; Martínez-López J
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31185671
[TBL] [Abstract][Full Text] [Related]
16. Next-generation sequencing of cancer genomes: lessons learned.
Corrigan AE; Taylor R; Rallis KS
Future Oncol; 2021 Nov; 17(31):4041-4044. PubMed ID: 34431364
[No Abstract] [Full Text] [Related]
17. Korean Society for Genetic Diagnostics Guidelines for Validation of Next-Generation Sequencing-Based Somatic Variant Detection in Hematologic Malignancies.
Kim H; Yun JW; Lee ST; Kim HJ; Kim SH; Kim JW;
Ann Lab Med; 2019 Nov; 39(6):515-523. PubMed ID: 31240878
[TBL] [Abstract][Full Text] [Related]
18. Enhanced clinical assessment of hematologic malignancies through routine paired tumor and normal sequencing.
Ptashkin RN; Ewalt MD; Jayakumaran G; Kiecka I; Bowman AS; Yao J; Casanova J; Lin YD; Petrova-Drus K; Mohanty AS; Bacares R; Benhamida J; Rana S; Razumova A; Vanderbilt C; Balakrishnan Rema A; Rijo I; Son-Garcia J; de Bruijn I; Zhu M; Lachhander S; Wang W; Haque MS; Seshan VE; Wang J; Liu Y; Nafa K; Borsu L; Zhang Y; Aypar U; Suehnholz SP; Chakravarty D; Park JH; Abdel-Wahab O; Mato AR; Xiao W; Roshal M; Yabe M; Batlevi CL; Giralt S; Salles G; Rampal R; Tallman M; Stein EM; Younes A; Levine RL; Perales MA; van den Brink MRM; Dogan A; Ladanyi M; Berger MF; Brannon AR; Benayed R; Zehir A; Arcila ME
Nat Commun; 2023 Oct; 14(1):6895. PubMed ID: 37898613
[TBL] [Abstract][Full Text] [Related]
19. The Interpretation of Sequence Variants in Myeloid Neoplasms.
Hanbazazh M; Harada S; Reddy V; Mackinnon AC; Harbi D; Morlote D
Am J Clin Pathol; 2021 Oct; 156(5):728-748. PubMed ID: 34155503
[TBL] [Abstract][Full Text] [Related]
20. Mutational spectrum and risk stratification of intermediate-risk acute myeloid leukemia patients based on next-generation sequencing.
Wang B; Liu Y; Hou G; Wang L; Lv N; Xu Y; Xu Y; Wang X; Xuan Z; Jing Y; Li H; Jin X; Deng A; Wang L; Gao X; Dou L; Liang J; Chen C; Li Y; Yu L
Oncotarget; 2016 May; 7(22):32065-78. PubMed ID: 27062340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
